Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Corium
Corium
(CORI)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Adlarity
Donepezil
2022-03-11
2025-2038
Alzheimer disease
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Donepezil
alzheimer disease
,
dementia
Donepezil hydrochloride
alzheimer disease
,
dementia
Enoblituzumab
malnutrition
,
rosacea
,
acne vulgaris
,
actinic keratosis
,
keratosis
,
erythema
,
asthma
,
allergic rhinitis
,
rhinitis
,
allergic rhinitis seasonal
,
ankle injuries
,
acute pain
,
sprains and strains
,
hypertension
,
ocular hypertension
,
glaucoma
,
open-angle glaucoma
,
inflammation
,
bacterial vaginosis
,
vaginal diseases
,
pruritus vulvae
,
vaginal discharge
,
cataract
,
lice infestations
,
pediculus
,
healthy volunteers/patients
,
drug-related side effects and adverse reactions
,
parkinson disease
,
neurogenic urinary bladder
,
urinary incontinence
,
enuresis
,
macular edema
,
dry eye syndromes
,
sjogren's syndrome
Phenylacetic acid
healthy volunteers/patients
,
knee osteoarthritis
,
hip osteoarthritis
,
actinic keratosis
,
keratosis
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use